Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA
Clinical trial NCT04097379 · COMPLETED
Trial details
- NCT number
- NCT04097379
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2024-08-08
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.